Last reviewed · How we verify
NCT07341178
Clinical Trial on Rapid Effects on Stem Cell Surveillance. A Randomized Placebo-controlled Acute Cross-over Trial.
NA trial testing Anthocyanin-rich berry extract in Stem Cell Surveillance in 48 participants. Not yet recruiting.
1 January 2027
Quick facts
| Lead sponsor | Natural Immune Systems Inc |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 48 |
| Start date | 1 January 2026 |
| Primary completion | 1 January 2027 |
| Estimated completion | 1 March 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Anthocyanin-rich berry extract
- Anthocyanin-rich flower/leaf extract
- Berry /leaf blend
- Placebo
Conditions studied
- Stem Cell Surveillance — all drugs for Stem Cell Surveillance →
Sponsor
Natural Immune Systems Inc
Who can join
Adults 18 to 75, any sex, with Stem Cell Surveillance. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Stem cell surveillance
Time frame: Baseline, 1 hour, 2 hours after consumption
Changes to the number of stem cells in the blood circulation (number of cells per mL blood). Data is collected on the following types of stem cells: CD45dimCD34+CD309+, CD45dimCD34+CD309-, CD31++CD34-, CD45-CD90+.
Sponsor's own description
The goal for this clinical trial is to compare acute immune effects of three nutraceutical ingredients and blends to a placebo.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07341178
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stem Cell Surveillance
Currently open trials in the same condition.
- NCT07127705 — Rapid Response of Stem Cells and Immune Cells for Efficacy · NA · recruiting
Other Natural Immune Systems Inc trials
Trials by the same sponsor.
- NCT07206407 — Clinical Trial on Rapid Immune Modulating Effects · NA · recruiting
- NCT07127705 — Rapid Response of Stem Cells and Immune Cells for Efficacy · NA · recruiting
- NCT06754228 — Acute Immune Modulation by Probiotic Strain · NA · recruiting
- NCT07142720 — Rapid Effects on Antioxidant Status, Immune Alertness, and Regenerative Activity · NA · completed
- NCT05176678 — Immunological Effect of Increasing Doses of Natural Peptide · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07341178 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Natural Immune Systems Inc
- Last refreshed: 6 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07341178.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing